Key result
HMGB1 drives multi-organ complications in diabetes mellitus across cardiovascular and microvascular systems.
Answers are grounded in this paper and cite their sources.
Diabetes mellitus (DM) is an endemic disease, with growing health and social costs. The complications of diabetes can affect potentially all parts of the human body, from the heart to the kidneys, peripheral and central nervous system, and the vascular bed. Although many mechanisms have been studied, not all players responsible for these complications have been defined yet. High Mobility Group Box-1 (HMGB1) is a non-histone nuclear protein that has been implicated in many pathological processes, from sepsis to ischemia. The purpose of this review is to take stock of all the most recent data available on the role of HMGB1 in the complications of DM.
No takes yet. Share an insight, caveat, or question.
Biscetti et al. (2019) conducted a review in Diabetes mellitus complications. High Mobility Group Box-1 (HMGB1) was evaluated. High Mobility Group Box-1 (HMGB1) is implicated in the pathogenesis of diabetes mellitus complications across multiple organ systems (narrative review; no quantitative outcomes reported).
Synapse has enriched 10 related papers. Consider them for comparative context: